Clinical Trials Browser

Phase 1 × INDUSTRY × balstilimab × Clear all

Advanced Solid Tumor

NCT03860272 2025-02-06

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

GastrointestinalGenitourinaryGynecologicSarcomaThoracic

Fibrolamellar hepatocellular carcinoma, Carcinoma, Non-Small-Cell Lung, Hemangiosarcoma, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Clinical Trials

Study of AGEN1571 in Participants With Advanced Solid Tumors

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer